CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

henagliflozin

Small moleculeexperimental

Clinical trial activity

34 trials · 21 clinical orgs · 0 marketing orgs

Phase 1
15
Phase 2
4
Phase 3
3
Phase 4
10

Earliest trial started Jun 1, 2013 (NCT02356224)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2017

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CCOc1ccc(Cc2cc([C@@]34OC[C@@](CO)(O3)[C@@H](O)[C@H](O)[C@H]4O)ccc2Cl)cc1F
Mol. weight
454.88 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • henagliflozin
  • shr3824
  • shr3824

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07294495N/AJan 7, 2026Huazhong University of Science and Technology
NCT06818851Phase 4Jul 14, 2025Hengrui Therapeutics, Inc., Jiao Tong University
NCT07027774Phase 4Jul 10, 2025Hengrui Therapeutics, Inc., Wannan Medical College
NCT06888050Phase 4Apr 11, 2025Suzhou Suncadia Biopharmaceuticals Co., Ltd., Zhejiang University
NCT06762223Phase 4Dec 31, 2024Hengrui Therapeutics, Inc., Nanjing Medical University
NCT06495931Phase 1Jul 31, 2024Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06448130Phase 4Jun 30, 2024Shandong Provincial Hospital
NCT06449833Phase 4Jun 30, 2024Southern Medical University
NCT06221059Phase 2Mar 2, 2024Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT06218342Phase 4Feb 15, 2024Zhejiang University
NCT06216340Phase 4Feb 15, 2024Jiangsu University, Nanjing Medical University, Soochow University, The First People's Hospital of Changzhou, The First People's Hospital of Lianyungang, Wuxi People's Hospital, Xuzhou Medical University, Yanshi People’s Hospital
NCT06031389N/AJan 1, 2024Shandong Province Qianfoshan Hospital
NCT06059287N/AOct 1, 2023Jiao Tong University
NCT06085703N/ASep 1, 2023Nanjing University
NCT06187727Phase 4Jul 1, 2023People's Liberation Army of China
NCT05742230N/AApr 15, 2023Zhejiang University
NCT05677334Phase 4Mar 1, 2023Hacettepe University
NCT05692934Phase 1Jan 31, 2023Suzhou Suncadia Biopharmaceuticals Co., Ltd.
NCT05252624Phase 3Sep 1, 2022Capital Medical University
NCT05108350Phase 1Nov 9, 2021Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Showing 20 of 34 trials
Page 1 / 2

Organizations

Research & Development (21)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Hengrui Therapeutics, Inc.For profit171432013
Suzhou Suncadia Biopharmaceuticals Co., Ltd.For profit5432021
Zhejiang UniversityAcademic/Hospital3322023
Jiao Tong UniversityAcademic/Hospital2222023
Nanjing Medical UniversityAcademic/Hospital2112024
Capital Medical UniversityAcademic/Hospital1112022
Hacettepe UniversityAcademic/Hospital1112023
Huazhong University of Science and TechnologyAcademic/Hospital1112026
Jiangsu UniversityAcademic/Hospital1012024
Nanjing UniversityAcademic/Hospital1112023
People's Liberation Army of ChinaGovernment1112023
Shandong Province Qianfoshan HospitalAcademic/Hospital1112024
Shandong Provincial HospitalAcademic/Hospital1112024
Soochow UniversityAcademic/Hospital1012024
Southern Medical UniversityAcademic/Hospital1112024
The First People's Hospital of ChangzhouAcademic/Hospital1112024
The First People's Hospital of LianyungangAcademic/Hospital1012024
Wannan Medical CollegeAcademic/Hospital1112025
Wuxi People's HospitalAcademic/Hospital1012024
Xuzhou Medical UniversityAcademic/Hospital1012024
21 organizations
Page 1 / 2